Fred M Powell Insider Trading
Get free email notifications about insider trading for Fred M Powell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fred M Powell. Fred M Powell is an Executive Vice President & CFO in ANTARES PHARMA, INC. ($ATRS) and a Senior Vice President & CFO in ANTARES PHARMA, INC. ($ATRS) and a Chief Financial Officer in BMP Sunstone CORP ($BJGP.PK) and a Chief Financial Officer in Celator Pharmaceuticals Inc ($CPXX) and a See Remarks in Celator Pharmaceuticals Inc ($CPXX) and a Vice President and CFO in Celator Pharmaceuticals Inc ($CPXX) and a VP and Chief Financial Officer in Celator Pharmaceuticals Inc ($CPXX).
Address: C/O BEIJING MED PHARM CORP 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING 19462 PA
Companies in which Fred M Powell is an Insider
ANTARES PHARMA, INC.
Trading Symbol: ATRSIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Fred M Powell: Executive Vice President & CFO, Senior Vice President & CFO
Holdings: 704,886 shares
Current Value: $1,550,749
Latest Transaction: Jun 10 2021
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BMP Sunstone CORP
Trading Symbol: BJGP.PKIndustry: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
Position of Fred M Powell: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Celator Pharmaceuticals Inc
Trading Symbol: CPXXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Fred M Powell: See Remarks, Vice President and CFO, VP and Chief Financial Officer, Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jul 12 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Fred M Powell
Sentiment: All, ATRS, BJGP.PK, CPXX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 4.39 | 12,045 | 52,878 | 704,886 | 716.9 K to 704.9 K (-1.68 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 4.73 | 35,829 | 169,471 | 691,001 | 726.8 K to 691 K (-4.93 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 0.00 | 80,365 | 0 | 726,830 | 646.5 K to 726.8 K (+12.43 %) |
Nov 16 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Buy | P | 2.85 | 16,400 | 46,740 | 646,465 | 630.1 K to 646.5 K (+2.60 %) |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Option Exercise | A | 2.73 | 254,165 | 693,870 | 254,165 | |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 2.78 | 8,564 | 23,808 | 630,065 | 638.6 K to 630.1 K (-1.34 %) |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 2.73 | 131,868 | 360,000 | 638,629 | 506.8 K to 638.6 K (+26.02 %) |